Insight Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
4,592
-61
| -1% | -$2.82K | 0.03% | 262 |
|
|
2025
Q1 | $284K | Buy |
4,653
+382
| +9% | +$23.3K | 0.05% | 220 |
|
|
2024
Q4 | $239K | Buy |
4,271
+80
| +2% | +$4.48K | 0.04% | 251 |
|
|
2024
Q3 | $217K | Buy |
+4,191
| New | +$217K | 0.04% | 273 |
|
|
2024
Q2 | – | Sell |
-4,271
| Closed | -$232K | – | 289 |
|
|
2024
Q1 | $232K | Sell |
4,271
-48
| -1% | -$2.6K | 0.04% | 268 |
|
|
2023
Q4 | $222K | Sell |
4,319
-257
| -6% | -$13.2K | 0.05% | 259 |
|
|
2023
Q3 | $266K | Sell |
4,576
-1,731
| -27% | -$100K | 0.06% | 221 |
|
|
2023
Q2 | $403K | Buy |
6,307
+38
| +0.6% | +$2.43K | 0.09% | 170 |
|
|
2023
Q1 | $435K | Sell |
6,269
-194
| -3% | -$13.4K | 0.1% | 170 |
|
|
2022
Q4 | $467K | Buy |
6,463
+118
| +2% | +$8.53K | 0.16% | 166 |
|
|
2022
Q3 | $451K | Buy |
6,345
+65
| +1% | +$4.62K | 0.18% | 151 |
|
|
2022
Q2 | $453K | Sell |
6,280
-241
| -4% | -$17.4K | 0.15% | 168 |
|
|
2022
Q1 | $476K | Sell |
6,521
-98
| -1% | -$7.15K | 0.14% | 182 |
|
|
2021
Q4 | $413K | Sell |
6,619
-720
| -10% | -$44.9K | 0.12% | 202 |
|
|
2021
Q3 | $435K | Buy |
7,339
+51
| +0.7% | +$3.02K | 0.13% | 194 |
|
|
2021
Q2 | $496K | Sell |
7,288
-923
| -11% | -$62.8K | 0.16% | 170 |
|
|
2021
Q1 | $513K | Buy |
8,211
+416
| +5% | +$26K | 0.16% | 157 |
|
|
2020
Q4 | $484K | Buy |
+7,795
| New | +$484K | 0.18% | 145 |
|